CZ2001655A3 - Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby - Google Patents

Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby Download PDF

Info

Publication number
CZ2001655A3
CZ2001655A3 CZ2001655A CZ2001655A CZ2001655A3 CZ 2001655 A3 CZ2001655 A3 CZ 2001655A3 CZ 2001655 A CZ2001655 A CZ 2001655A CZ 2001655 A CZ2001655 A CZ 2001655A CZ 2001655 A3 CZ2001655 A3 CZ 2001655A3
Authority
CZ
Czechia
Prior art keywords
amino acid
peptide
hydrophobic amino
acid
seq
Prior art date
Application number
CZ2001655A
Other languages
Czech (cs)
English (en)
Inventor
David E. Wright
John S. O´Brien
Original Assignee
Myelos Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corporation filed Critical Myelos Corporation
Publication of CZ2001655A3 publication Critical patent/CZ2001655A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CZ2001655A 1998-08-28 1999-08-20 Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby CZ2001655A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28

Publications (1)

Publication Number Publication Date
CZ2001655A3 true CZ2001655A3 (cs) 2001-11-14

Family

ID=22268937

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2001655A CZ2001655A3 (cs) 1998-08-28 1999-08-20 Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby

Country Status (13)

Country Link
EP (1) EP1105420A1 (pt)
JP (2) JP4528443B2 (pt)
KR (1) KR20010079695A (pt)
CN (1) CN1324367A (pt)
AU (1) AU751034B2 (pt)
BR (1) BR9913490A (pt)
CA (1) CA2341810A1 (pt)
CZ (1) CZ2001655A3 (pt)
HU (1) HUP0103265A3 (pt)
IL (1) IL141586A0 (pt)
PL (1) PL204359B1 (pt)
WO (1) WO2000012553A1 (pt)
ZA (1) ZA200102489B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
BR9913490A (pt) * 1998-08-28 2001-09-25 Myelos Corp Prosaposina cìclicos e seus usos
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
US9271932B2 (en) 2006-04-28 2016-03-01 Children's Hospital Medical Center Fusogenic properties of saposin C and related proteins and peptides for application to transmembrane drug delivery systems
CA2666953A1 (en) * 2006-10-20 2008-05-02 Children's Hospital Medical Center Spontaneous forming ellipsoidal phospholipid unilamellar vesicles
CN103275187B (zh) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 一种镇痛肽fi及其基因和应用
WO2016172409A1 (en) 2015-04-23 2016-10-27 The Procter & Gamble Company Delivery of surfactant soluble anti-dandruff agent
CA3014923C (en) 2016-03-03 2021-10-19 Sean Michael Renock Aerosol antidandruff composition
CN109843383A (zh) 2016-10-21 2019-06-04 宝洁公司 用于在最佳制剂空间中递送消费者期望的剂量体积、表面活性剂量和头皮健康剂量的泡沫剂型
CN109862944A (zh) 2016-10-21 2019-06-07 宝洁公司 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型
WO2018075836A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
EP3528774A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam designating hair volume benefits
WO2018075846A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam designating hair conditioning benefits
JP6952768B2 (ja) 2016-10-21 2021-10-20 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 低粘度であり粘度低減剤を含む、安定なコンパクトシャンプー製品
US10653590B2 (en) 2016-10-21 2020-05-19 The Procter And Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits comprising an anionic/zwitterionic surfactant mixture
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US20190105246A1 (en) 2017-10-10 2019-04-11 The Procter & Gamble Company Sulfate free personal cleansing composition comprising low inorganic salt
WO2019074988A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company METHOD OF TREATING HAIR OR SKIN WITH PERSONAL FOAM COMPOSITION IN THE FORM OF FOAM
JP6945746B2 (ja) 2017-10-10 2021-10-06 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ サルフェートフリーの界面活性剤を含有するコンパクトなシャンプー組成物
MX2020003318A (es) 2017-10-10 2021-12-06 Procter & Gamble Composición de champú compacta con surfactantes aniónicos a base de aminoácidos y polímeros catiónicos.
US10912732B2 (en) 2017-12-20 2021-02-09 The Procter And Gamble Company Clear shampoo composition containing silicone polymers
MX2020014144A (es) 2018-06-29 2021-03-25 Procter & Gamble Composicion anticaspa en aerosol con bajo contenido de surfactante.
MX2022005533A (es) 2019-12-06 2022-06-08 Procter & Gamble Composicion libre de sulfato con deposito mejorado del activo para el cuero cabelludo.
JP7481470B2 (ja) 2020-02-27 2024-05-10 ザ プロクター アンド ギャンブル カンパニー 有効性及び美観が強化された硫黄含有フケ防止組成物
JP2023549517A (ja) 2020-12-04 2023-11-27 ザ プロクター アンド ギャンブル カンパニー 悪臭低減物質を含むヘアケア組成物
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
BR9913490A (pt) * 1998-08-28 2001-09-25 Myelos Corp Prosaposina cìclicos e seus usos

Also Published As

Publication number Publication date
KR20010079695A (ko) 2001-08-22
JP4528443B2 (ja) 2010-08-18
ZA200102489B (en) 2002-06-04
JP2002523518A (ja) 2002-07-30
PL204359B1 (pl) 2010-01-29
IL141586A0 (en) 2002-03-10
PL346346A1 (en) 2002-02-11
EP1105420A1 (en) 2001-06-13
HUP0103265A3 (en) 2002-09-30
BR9913490A (pt) 2001-09-25
AU751034B2 (en) 2002-08-08
WO2000012553A1 (en) 2000-03-09
HUP0103265A2 (hu) 2002-02-28
CA2341810A1 (en) 2000-03-09
CN1324367A (zh) 2001-11-28
AU5690599A (en) 2000-03-21
JP2010150272A (ja) 2010-07-08

Similar Documents

Publication Publication Date Title
CZ2001655A3 (cs) Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby
RU2266129C2 (ru) Способ воздействия на нейродегенеративное нарушение или нарушение миелинизации
US20050164948A1 (en) Methods of treatment with prosaposin-derived peptides
AU751161B2 (en) Retro-inverso neurotrophic and analgesic peptides
CA2282827A1 (en) Method of alleviating neuropathic pain
WO1998042746A9 (en) Synthetic saposin c-derived neurotrophic peptides
AU7795698A (en) Synthetic saposin c-derived neurotrophic peptides
US20020128193A1 (en) Retro-inverso prosaposin-derived peptides and use thereof
MXPA01001966A (en) Cyclic prosaposin-derived peptides and uses thereof
AU2002300005B2 (en) Method of alleviating neuropathic pain
AU4267297A (en) Method of alleviating neuropathic pain
MXPA98007245A (en) Methods to alleviate neuropathic pain using peptides derived from prosapos